Clinical Trial Update: Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients

View source ↗

Summary

A clinical trial evaluating novel biomarkers for assessing interstitial lung disease in rheumatoid arthritis patients; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Rheumatoid Arthritis

Snippet

Sponsor: Assiut University | Conditions: Rheumatoid Arthritis, Interstitial Lung Disease | Status: NOT_YET_RECRUITING